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Introduction 
It is estimated that 1014 microorganisms make up the 
human microbiome [1]. There is increasing evidence 
to support the significant role in human health of this 
diverse ecosystem made up of bacteria, fungi, 
viruses, and eukaryotes [2, 3]. Although much of the 
research done on the human microbiome has been 
related to the gastrointestinal tract, it has been 
shown that the microorganisms that live on humans 
can also affect the skin. The delicate balance of these 
rich communities of microorganisms is believed to 
contribute to skin barrier function, immunity, and 
lipid formation [4, 5]. Furthermore, a disruption of 
the skin microbiome has been associated with 
different diseases states such as atopic dermatitis, 
acne, and psoriasis [6-8]. Therefore, studying these 
microbial communities is vital to gaining insight into 
the various physiological and pathophysiological 
states of the skin. 
In his essay “The Law of Accelerating Returns,” author 
Ray Kurzweil argues that technology is advancing at 
an exponential rate. He argues that despite humans 
holding an “intuitive linear” perspective for 
technology growth, if one examines our ancestors or 
even biological evolution as a whole, it becomes 
strikingly clear that progress is being made in an 
exponential fashion. As it relates to genomic 
sequencing and bioinformatics technology, there 
has recently been a dramatic shift in how the skin 
microbiome is studied. Instead of examining skin 
microbiota communities through culture-based 
protocols, scientists have transitioned to applying 
sequencing techniques such as amplicon or whole  
Abstract 
The role of the microbiome in healthy and disease 
states of the human body is progressively being 
found to extend beyond the gastrointestinal tract 
and into other organ systems such as the skin. 
Researching the microbiome thus has become 
paramount to understanding additional 
physiological and pathophysiological mechanisms 
that may be at play between microbes and their 
hosts. Cell cultures have traditionally been used to 
study the microbiome, but in our current day and 
age, advanced metagenomic techniques — such as 
16S rRNA amplicon sequencing and whole 
metagenomic shotgun sequencing — are better 
able to classify the microorganisms making up the 
microbiome. Utilizing metagenomics alone, 
however, does not allow for the study of the more 
complex effects of the microbiome, such as 
changes in gene expression and metabolic 
byproducts. Thus, incorporation of other modalities such 
as metatranscriptomics, metaproteomics, and 
metabolomics are needed to further elucidate the 
extensive intricacies of the skin microbiome. 
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metagenomic shotgun sequencing — collectively 
known as metagenomics [9]. Although growing 
microbes in vitro has been an effective method in the 
past, culturing microorganisms in the laboratory 
setting erroneously underestimates the 
phylogenetic diversity of the skin microbiome [9, 10]. 
This underestimation is a byproduct of the bias that 
comes with culturing bacteria in a laboratory setting. 
For example, some species flourish more readily in 
artificial growth settings than others, effectively 
skewing data [9, 11]. Recognition of this limitation, 
combined with technological advances and cost 
reductions, are the motivating factors in researchers’ 
decisions to utilize sequencing techniques in skin 
microbiome studies. 
The progression to culture-independent profiling 
has ushered in a new era for microbiome research 
and revolutionized our understanding of the skin 
microbiome [12]. Yet, despite the development of 
higher resolution techniques, most skin microbiome 
researchers only utilize metagenomic sequencing for 
taxonomic classifications. With our knowledge of the 
skin microbiome expanding rapidly, it has become 
apparent that the pathogenesis of various skin 
diseases arises from more than just changes in 
microbial composition. Changes in gene expression, 
production of metabolites, and microbial 
interactions with the host are all factors that play a 
pivotal role in deepening our collective knowledge 
and elucidating the influence of the skin microbiome 
in disease. In this regard, it has become apparent that 
utilizing metagenomics alone without the other 
‘omics’ (metatranscriptomics, metaproteomics, and/or 
metabolomics) paints a very limited picture of the skin 
microbiome. Table 1 summarizes the modalities 
used in the analysis of the skin microbiome. Herein, 
we review the methodology behind amplicon and 
whole metagenomic sequencing and discuss the 
need to incorporate the other “omics” in skin 
microbiome research moving forward. 
Metagenomics 
At present, the two most common next generation 
sequencing techniques are 16S rRNA amplicon 
sequencing (16S) and whole metagenomic shotgun 
sequencing (WMS). Metagenomics collectively refers 
to the genomic analysis of a group of 
microorganisms using DNA extraction and 
replication techniques [13]. 
Amplicon sequencing 
16S rRNA sequencing, also known as 
metataxonomics, involves selecting primers that 
bind to a specific portion of the highly conserved 
bacterial hypervariable loop region followed by PCR 
amplification of this region [14]. Recent studies have 
indicated that 16S tag primers for the V1-V3 region 
have yielded the most accurate and encompassing 
results in terms of bacterial abundances and genus 
classification [14]. The actual steps in performing 16S 
amplicon sequencing include: collection of 
cutaneous samples, bacterial DNA isolation and 
annealing of selected hypervariable loop primer, and  
amplification of the selected bacterial region 
through PCR sequencing [14]. 
Once the samples are sequenced and the results are 
collected, researchers are tasked with analyzing the 
metadata, which is typically done using programs 
such as Mothur or QIIME. The analysis pipeline can be 
broken down into three steps: preprocessing, 
clustering operational taxonomic units (OTUs), and 
annotating OTU tables [14]. Preprocessing can be 
likened to a quality assurance checkpoint, in which 
low quality reads and PCR generated chimeric 
sequences are filtered out. Clustering OTUs is 
essentially the grouping of similar sequences 
together. The last step of the analysis, annotation of 
OTU tables, is the process of comparing clustered 
OTUs to known reference databases (Silva132, 
GreenGenes, RDP) in order to assign the 
appropriate taxonomic classification to the clustered 
sequences [14]. 
Although what was described above discusses the 
methodology for targeting and sequencing bacterial 
genomes, amplicon sequencing is not limited to 
prokaryotic organisms. By targeting conserved 
ribosomal RNA genes specific to fungi, it becomes 
possible to amplify and sequence eukaryotic 
genomes as well [15]. Typically, the three most 
conserved and targeted regions used in fungal 
metagenomics are internal transcribed spacer (ITS1–
ITS2), 18S ribosomal small subunit RNA gene, or 
D1/D2 domain of the 26S ribosomal large subunit 
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Table 1. Various Methods Used to Study the Microbiome  
Technique Description Pros Cons 
Culture 
Growing microbes on a 
culture media in the confides 
of a laboratory setting 
Cost effective and relatively simple to 
perform 
Can grow populations from a single cell 
Able to isolate and selectively grow a 
particular microorganism    
Bias toward bacteria that grow in 
artificial settings 
Significantly less sensitive in 
bacterial detection as compared 
to DNA methods 
Dramatically underestimates 
bacterial diversity in collected 
samples 
Metagenomics- 
Amplicon 
Targeting specific conserved 
genomic regions found in 
microbes in order to 
determine taxonomical 
classifications 
Comprehensive reference databases 
Capable of analyzing large number of 
samples  
Plethora of usable primers  
Selected variable region primers 
(V1-V3 and V4) can lead to 
skewed estimates of relative 
abundance 
Samples are subject to PCR 
amplification bias (i.e. chimera 
generation) 
Taxonomical classifications are 
typically limited to phyla and 
genera levels  
Metagenomics- 
WMS 
Parallel sequencing of 
thousands of different 
organisms that may 
otherwise be unculturable, in 
order to determine 
taxonomic classifications 
Confidently assigns classifications for 
many sequences at the species level and 
in some instances at strain level 
Allows for simultaneous study of 
prokaryotes, archaea, viruses, 
virophages, and eukaryotes 
Can be complemented with 
metatranscriptomics, proteomics, 
metabolomics and metadata to derive 
mechanistic models that explain the 
structure and function of the microbiome 
Library preparations/sequencing 
costs 5x more compared to 16S 
methods 
Susceptible to contamination of 
human DNA when there is low 
biomass available 
More difficult to analyze data 
because of significantly larger 
orders of magnitude of data that 
is generated requiring filtering 
from human sequences. 
Metatranscript
omics 
All RNA present in the 
microbial community is 
sequenced in order to 
determine level of 
expressional of the genes 
present and gain insight into 
the active metabolic 
pathways 
Capacity to elucidate functional 
expression in collected samples 
Potential to reconstruct active metabolic 
pathways in microbial community 
Possible to determine a specific 
protein’s rate of production  
Cost Intensive 
Difficulty in purifying mRNA 
from rRNA  
Based on how samples are 
collected, high potential of 
contamination by host RNA 
Relatively small and limited 
number of reference databases 
Metaproteomics 
The functional 
characterization of the 
microbial community via 
measurement of protein 
abundances and 
determination of protein 
species 
Can characterize all gene translation 
products 
Provides insights on post translational 
modification  
Offers information on protein stability 
and localization  
Cannot provide information on 
protein abundance  
Subject to inefficient chemical 
labeling leading to 
compromised biological 
coverage   
Metabolomics 
The detection of metabolites 
and by-products of microbial 
activity, providing insight 
into the subtleties of how 
microbes may be 
communicating together 
Analyses of hundreds of metabolites in a 
given sample  
High predictive capacity for phenotype 
Resolution of microbial metabolic 
products/ signaling molecules  
Cost Intensive 
Rather nascent - currently not 
possible to translate all the data 
produced into a meaningful 
biological context  
Known data bases may contain 
low quality reference MS spectra  
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RNA gene [16]. Like amplicon sequencing in 
prokaryotes, DNA is isolated from the samples of 
interest and the selected primers targeting a 
conserved region are introduced to the sample and 
undergo amplification via PCR. The generated reads 
are filtered and analyzed by programs, such as QIIME, 
until data satisfactory to the researchers’ standards is 
produced. The filtered data is compared to online 
databases (UNITE) for sequence homology and 
taxonomic classification. Although ITS1–ITS2 tends 
to be the region most targeted for fungal amplicon 
sequencing, it has been shown that the variability in 
length of this region between different organisms 
generates erroneous estimations of their relative 
abundances. Thus, it is suggested that researchers 
use primers targeting 18S or 26S regions in order to 
generate more accurate and reliable data [16]. 
In the past, amplicon sequencing was the gold 
standard for microbiome research and in some 
instances still is today. The utility of amplicon 
sequencing relates to the multiple comprehensive 
genomic reference databases that exist (Silva132, 
GreenGenes, RDP, UNITE) as well as the affordability 
and relative ease of performing this technique [17]. 
Although this form of metagenomics has been a 
powerful tool in skin microbiome research, it comes 
with inherent disadvantages. 
The major drawbacks that come with amplicon 
sequencing are related to over exploitation of the 
conserved sequences within a genome. For example, 
preferential selection of primers for a region of 
interest generates a bias in the collected sample and 
can lead to various organisms being over or 
underrepresented. Furthermore, PCR amplification 
has the propensity to generate chimeric sequences 
within the collected samples being sequenced. 
Therefore, skewing or lowering the quality of the 
reads and possible misrepresentation of the 
taxonomic diversity can occur. In a parallel light, 
taxonomic classification of samples sequenced 
through amplicon methods tend be constrained to 
the phyla, and to a lesser extent, genera levels. With 
these limitations becoming more apparent over 
time, newer technologies have been invented in 
hopes to overcome these constraints [12, 17, 18]. 
Whole metagenomic shotgun sequencing 
Whole metagenomic shotgun sequencing (WMS) is a 
newer next generation sequencing technology with 
the capacity to identify approximately twice as many 
species than amplicon sequencing at certain read 
depths. It also provides information on the 
functional potential of the sampled genes [19]. 
Similar to the methodology for amplicon 
sequencing, whole metagenomic shotgun 
sequencing requires collection of cutaneous 
samples, but instead of using primers to isolate and 
amplify the gene of interest, all collected DNA 
samples are sheared into small fragments and 
sequenced independently [14]. The small amplified 
sequences produced, known as contigs, are 
arranged to recreate their respective genomes and 
are compared against online reference databases to 
determine the organisms from which the DNA 
originated. WMS confidently assigns classifications 
to many sequences at the species level and in some 
instances at the strain level. This is all done while 
simultaneously enabling the study of prokaryotes, 
archaea, viruses, virophages, and eukaryotes along 
with functional potential classification of the 
associated gene sequences, ultimately driving the 
discovery of new microbial genes and genomes. 
Even though WMS provides insights into the 
functional potential of collected samples, it cannot 
resolve the level of expression of any of the present 
genes [19]. Therefore, the true value of using WMS is 
a result of its capacity to be coupled with the other 
‘omics’ (metatranscriptomics/proteomics/metabolomics) 
to generate metadata that can explain the structure 
and function of the microbiome with greater 
precision and accuracy. 
The major drawbacks of whole metagenomic 
shotgun sequencing can be narrowed down into 
two factors - cost and intensity to perform. To 
amplify the small sheared DNA fragments and 
analyze the resulting data is significantly more 
expensive and intense than amplicon sequencing. 
WMS is also constrained to adequate read depths in 
order to obtain accurate results, which can be 
difficult to achieve in skin microbiome research, 
although significant advances have been made to 
ameliorate the problem. Researchers encounter 
challenges in analyzing shotgun metagenomic data 
occur because of the extensive filtering that is 
required as a result of sequencing all sampled DNA 
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(host + microbial), leading to data sets of significantly 
larger orders of magnitude. Thus, analyses of WMS 
data take longer to perform and require far more 
computational power [20]. When utilizing WMS for 
skin samples, the overabundance of host DNA 
relative to microbial organisms inhabiting the skin, 
requires researchers to use more targeted DNA 
isolation methods and filtration. Otherwise, the 
contigs produced from these reads could err on the 
side of inaccuracy and misrepresent the microbes 
present in the collected samples. 
Of the two technologies, WMS is being implemented 
increasingly in cutaneous microbiome research. This 
is partially related to the expanding size of the WMS 
reference databases and the more comprehensive 
and accurate nature of the technique, but it is mainly 
because of the reduction in read depth requirements 
and cost to perform [18]. 
Using a “Multi-Omic” approach 
As researchers shift to utilizing WMS in their projects, 
they should remain mindful of the benefits that exist 
when using a “multi-omic” approach. Metagenomics 
has given researchers a wealth of new information, 
but even then, classification of sampled 
representative sequences are limited to the 
organisms that have been cataloged in known 
reference databases [10]. In attempts to overcome 
these limitations and produce accurate data that is 
more representative of the skin ecosystem, 
researchers have begun coupling metagenomics 
with metatranscriptomics, metaproteomics, and/or 
metabolomics. 
Metatranscriptomics 
Metatranscriptomics can be defined as profiling of a 
metatranscriptome, or community wide gene 
expression. The strength of metatranscriptomics is 
the ability to elucidate functional expression of 
microbial genes of microorganisms, despite their 
ability to be grown in vitro [20]. When 
complemented with WMS, it becomes possible to 
gain accurate insights into expression levels of the 
sequences annotated by metagenomics. With access 
to such functional data, researchers can determine 
the metabolic pathways active in microbial 
communities in different environments and 
generate profound information pertinent to 
biomedical advances [20]. 
The typical procedure for metatranscriptomics 
begins by collecting samples and purifying the 
mRNA. Once isolated, the mRNA is converted to 
cDNA and sequenced concurrently with 
metagenomic samples [21]. The sequences 
produced are referred to as RNA-Seq and are 
compared to online databases, such as HUMAnN, for 
analyses [20]. 
Metatranscriptomics is seldom used in skin 
microbiome research despite the fact that it can be 
coupled with whole shotgun metagenomic 
sequencing. This can be attributed to the high cost of 
performing metatranscriptomic sequencing as 
well as the difficulty that comes with isolating mRNA 
from the samples. Even once mRNA samples are 
collected and isolated, mRNA has a short half-life and 
is degraded quickly, making it difficult to detect at 
times. Researchers are also faced with the possibility 
of contamination by host RNA depending on how 
the samples are collected (i.e. biopsies). The small, 
yet growing size of the databases to which the RNA-
Seqs are compared is another point of contention 
when considering utilization of metatranscriptomics 
[20]. However, despite these obstacles and 
constraints, when coupled with metagenomics, 
metatranscriptomics proves to be an immensely 
powerful tool for cutaneous microbiome researchers 
because it is capable of providing a more holistic 
view of the skin microbiome [20]. 
A recent study examined the effects of Vitamin B12 
in the pathogenesis of acne as modulated by 
microbiota. Using metatranscriptomics in order 
examine expression of the Vitamin B12 biosynthesis 
pathway in skin microbes, researchers discovered 
that supplementation of Vitamin B12 to the host 
repressed Vitamin B12 biosynthesis in the 
commensal skin species Cutibacterium acnes (C. 
acnes), one of the bacteria believed to have a role in 
the pathogenesis of acne. This increase in host 
vitamin B12 concentration also increased the 
concentration of porphyrins, chemicals shown to 
promote inflammation in acne, produced by C. acnes 
in the follicles of acne patients [22]. These discoveries 
suggest possibilities for the development of new 
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treatment options for acne. Evidently, as science 
marches forward, the combined use of multiple 
different ‘omic’ technologies will be necessary in 
order to yield data that truly represents the 
complexities of the skin microbiome in different 
environments. 
Metaproteomics 
Metaproteomics is defined as, “the large‐scale 
characterization of the entire protein complement of 
environmental microbiota at a given point in time” 
[23]. By knowing exactly what proteins are present 
and in what concentration, it allows for the 
resolution of the components in a microbial 
ecosystem that perpetuate its survival. Typically, the 
identification and quantification of protein species 
are measured via a shotgun-like methodology, in 
which peptides are sheared and undergo liquid 
chromatography–mass spectrometry [23, 24]. The 
resulting data reveal amino acid sequence, 
abundance, and the presence of any post 
translational modifications (i.e. phosphorylation of 
residues). Finally, the sequence homology is 
compared to online reference databases (i.e. Pipasic, 
MetaProteomeAnalyzer, Unipept) to determine the 
exact protein species present. Experts have 
suggested to compare the resulting data against 
multiple databases in order to yield the most 
accurate results [25]. Like WMS, metaproteomics can 
be used to analyze the expression of active 
functional pathways, but with more precision. In 
metatranscriptomics, measuring the amount of 
transcript present indicates the rate of production of 
its protein product. However, knowing the rate of 
protein production does not accurately relate to the 
concentration of the protein present nor does it 
speak about the protein’s stability. The appeal of 
metaproteomics is that it provides researchers more 
relevant and accurate data in terms of proteins [26]. 
To date, a very limited number of skin microbiome 
researchers have incorporated metaproteomics into 
their research designs. This is in stark contrast to 
what is seen with gut microbiome research in which 
various researchers are utilizing metaproteomics 
alongside metagenomic sequencing [25-27]. This 
disconnect between gut and skin microbiome 
research may exist for a number of reasons, such as 
limited read depths and/or cost restrictions. 
Nevertheless, as biotechnology continues to 
advance, the possibility for metaproteomics in 
cutaneous research becomes increasingly more 
viable. Metaproteomic techniques allow researchers 
to track functional genes and metabolic pathways, 
identify protein expression in various situations 
(such as microbes under stressors), and aid in 
alluding to new possible functional genes. All of 
these capabilities are instrumentally important in 
elucidating the role of microbes in skin disease 
pathogenesis.  
Metabolomics 
The final category of the four “omics” discussed here 
is known as metabolomics, which involves the 
identification and quantification of all metabolites 
present in a sample. Similar to metaproteomics, 
metabolites are identified and quantified through 
liquid/gas chromatography as well as mass 
spectrometry and nuclear magnetic resonance; the 
typically accurate results produced are contingent 
upon the purity of the collected samples. The spectra 
generated are subject to analyses and through it 
researchers are able to uncover the identity and 
abundances of metabolites present in the sample. 
Similar to comparing genomic sample sequences to 
known taxonomical databases, the generated 
metabolomic data is compared to known spectral 
databases, such as the Madison-Qingdao 
Metabolomics Consortium Database, in order to 
identify the sample metabolites [10]. As with 
metaproteomics, the majority of metabolomics 
research being conducted pertains to the gut 
microbiome rather than the skin microbiome. There 
have been a few pivotal skin metabolomic studies 
described in the literature, such as the work done by 
Kuehne et al. that demonstrated that there are only 
minor metabolomic and transcriptional changes as 
our skin ages [10, 28]. The field of lipidomics is a 
prime example of the role of metabolomics in 
cutaneous research, specifically regarding psoriasis. 
According to research by Zeng et al, lipid 
metabolites such as LDL-C, HDL-C, AND APOA-I have 
been found to be abnormal in serum lipids of 
psoriatic patients [29]. The researchers found that 
lysophosphatidic acid, lysophosphatidylcholine, and 
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phosphatidic acid were elevated in patients suffering 
from psoriasis, indicating a novel route of 
pathogenesis not previously examined in skin 
microbiome research. 
Despite cost barriers, utilization of metabolomics 
allows cutaneous researchers to examine the 
subtle nuances of microbial communities, such 
as the signaling processes used between 
bacteria in communication [10]. Coupled with WMS, 
metabolomics paves the way to reconstruct the 
intricacies of whole networks of microbial 
communities. 
Discussion 
As it stands, a majority of skin microbiome research 
conducted today still heavily relies on amplicon 
sequencing, both because it is the least laborious 
and least cost intensive. However, as biotechnology 
continues to advance, the utility of next generation 
sequencing methods, such as WMS, are proving to 
be more useful than its amplicon sequencing 
counterpart. By its ability to distinguish variations in 
organisms at the strain level and allowing predictive 
measures of the functional capacity of genes, WMS is 
starting to take hold in skin microbiome research. 
However, despite this shift towards WMS, a majority 
of skin microbiome researchers have yet to 
incorporate other ‘omic’ methods in their research 
deigns. Coupling metagenomic research with 
metatranscriptomics, metaproteomics, and/or 
metabolomics paints a much more comprehensive 
and detailed picture of what is occurring between 
the host and skin microbes in healthy and diseased 
states. As skin microbiome research progresses it will  
become imperative to look beyond just “what 
microbes are present?” and focus in on, “what are the 
microbes present doing?” The logical next step in 
furthering the knowledge of pathological conditions 
of the skin involves examining what microbes are 
producing, how are they producing it, and what the 
downstream effects of these products are. As the 
requirements for read depths and labor intensity 
decrease, it is inevitable that the other “omics” will 
make their way into skin microbiome research; it is 
just a matter of how quickly researchers are willing to 
adopt these practices [10]. 
Conclusion 
Today, researchers investigating the skin 
microbiome are placed into the unique position of 
being at the forefront of elucidating new information 
that was once considered out of reach. Gone are the 
limitations that encumbered scientists when 
growing microbes in vitro. With access to next 
generation sequencing technologies, investigators can 
now examine the nuanced interplays between 
microbes within the microbiome and between the 
microbes and host as well. With this wealth of new 
information being generated, we stand at the 
threshold of skin microbiome research. As we enter 
this new era ushered in by “omics” technology, one 
cannot help but think — what a time to be alive. 
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